119 related articles for article (PubMed ID: 8231247)
1. In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNA.
Lange W; Cantin EM; Finke J; Dölken G
Leukemia; 1993 Nov; 7(11):1786-94. PubMed ID: 8231247
[TBL] [Abstract][Full Text] [Related]
2. Investigating and improving the specificity of ribozymes directed against the bcr-abl translocation.
James H; Mills K; Gibson I
Leukemia; 1996 Jun; 10(6):1054-64. PubMed ID: 8667643
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of BCR/ABL mRNA by synthetic ribozymes--effects on the proliferation rate of K562 cells.
Lange W
Klin Padiatr; 1995; 207(4):222-4. PubMed ID: 7564157
[TBL] [Abstract][Full Text] [Related]
4. Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization.
Mendoza-Maldonado R; Zentilin L; Fanin R; Giacca M
Cancer Gene Ther; 2002 Jan; 9(1):71-86. PubMed ID: 11916246
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo effects associated with the expression of a bcr-abl-specific ribozyme in a CML cell line.
Wright LA; Milliken S; Biggs JC; Kearney P
Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):15-23. PubMed ID: 9512092
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.
Mahon FX; Ripoche J; Pigeonnier V; Jazwiec B; Pigneux A; Moreau JF; Reiffers J
Exp Hematol; 1995 Dec; 23(14):1606-11. PubMed ID: 8542954
[TBL] [Abstract][Full Text] [Related]
7. Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemia.
Wright L; Wilson SB; Milliken S; Biggs J; Kearney P
Exp Hematol; 1993 Dec; 21(13):1714-8. PubMed ID: 8243570
[TBL] [Abstract][Full Text] [Related]
8. An intron promotes the anti-bcr-abl activities of a retrovirally expressed ribozyme in chronic myeloid leukemia cells.
Liu JH; Wu SC; Chen WS; Yen CC; Yang MH; Tsai YC; Chen PM
Biochem Biophys Res Commun; 2004 Jun; 318(3):764-72. PubMed ID: 15144904
[TBL] [Abstract][Full Text] [Related]
9. [The effect of anti-bcr-abl hammerhead ribozyme on bone marrow purging].
Wu Y; Chen YZ; Huang HF; Chen P; Lu LH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Sep; 35(9):859-63. PubMed ID: 12958661
[TBL] [Abstract][Full Text] [Related]
10. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
[TBL] [Abstract][Full Text] [Related]
11. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
Wu AG; Joshi SS; Chan WC; Iversen PL; Jackson JD; Kessinger A; Pirruccello SJ; Sanger WG; Sharp JG; Verbik DJ
Leuk Lymphoma; 1995 Dec; 20(1-2):67-76. PubMed ID: 8750625
[TBL] [Abstract][Full Text] [Related]
12. [The effect of multi-unit ribozymes on the growth inhibition and apoptosis induction of CML K562 cells].
Feng Q; Sun B; Sun K; Shang Z; Wang S; Wang W; Zhao Y; Yan Z; Han W; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):435-9. PubMed ID: 12485492
[TBL] [Abstract][Full Text] [Related]
13. Comparison of activities between hammerhead ribozymes and DNA enzymes targeted to L6 BCR-ABL chimeric (b2a2) mRNA.
Warashina M; Kuwabara T; Taira K
Nucleic Acids Symp Ser; 1997; (37):213-4. PubMed ID: 9586075
[TBL] [Abstract][Full Text] [Related]
14. [Construction of retrovirus vector of bcr/abl mRNA cleaving ribozyme gene and its effects on K562 cells].
Wu Y; Chen Y; Hu J
Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):623-6. PubMed ID: 11263328
[TBL] [Abstract][Full Text] [Related]
15. LightCycler technology for the quantitation of bcr/abl fusion transcripts.
Kreuzer KA; Lass U; Bohn A; Landt O; Schmidt CA
Cancer Res; 1999 Jul; 59(13):3171-4. PubMed ID: 10397261
[TBL] [Abstract][Full Text] [Related]
16. Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells.
Withey JM; Marley SB; Kaeda J; Harvey AJ; Crompton MR; Gordon MY
Br J Haematol; 2005 May; 129(3):377-80. PubMed ID: 15842662
[TBL] [Abstract][Full Text] [Related]
17. Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity.
Shore SK; Nabissa PM; Reddy EP
Oncogene; 1993 Nov; 8(11):3183-8. PubMed ID: 8414522
[TBL] [Abstract][Full Text] [Related]
18. IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein.
Dilloo D; Hanenberg H; Lion T; Burdach S
Leukemia; 1995 Mar; 9(3):419-24. PubMed ID: 7885040
[TBL] [Abstract][Full Text] [Related]
19. Extremely high and specific activity of DNA enzymes in cells with a Philadelphia chromosome.
Warashina M; Kuwabara T; Nakamatsu Y; Taira K
Chem Biol; 1999 Apr; 6(4):237-50. PubMed ID: 10099134
[TBL] [Abstract][Full Text] [Related]
20. The molecular biology of chronic myeloid leukaemia.
Melo JV
Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]